260 related articles for article (PubMed ID: 37481650)
21. Recent advances in responsive antibacterial materials: design and application scenarios.
Zhang B; Lu D; Duan H
Biomater Sci; 2023 Jan; 11(2):356-379. PubMed ID: 36408610
[TBL] [Abstract][Full Text] [Related]
22. Emerging antibacterial nanomedicine for enhanced antibiotic therapy.
Wang S; Gao Y; Jin Q; Ji J
Biomater Sci; 2020 Dec; 8(24):6825-6839. PubMed ID: 32996490
[TBL] [Abstract][Full Text] [Related]
23. Antimicrobial Peptides Therapy: An Emerging Alternative for Treating Drug-Resistant Bacteria.
Mba IE; Nweze EI
Yale J Biol Med; 2022 Dec; 95(4):445-463. PubMed ID: 36568838
[TBL] [Abstract][Full Text] [Related]
24. Advances of functional nanomaterials for cancer immunotherapeutic applications.
Hao Y; Zhou X; Li R; Song Z; Min Y
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Mar; 12(2):e1574. PubMed ID: 31566896
[TBL] [Abstract][Full Text] [Related]
25. Immunotherapies against human bacterial and fungal infectious diseases: A review.
Qadri H; Shah AH; Alkhanani M; Almilaibary A; Mir MA
Front Med (Lausanne); 2023; 10():1135541. PubMed ID: 37122338
[TBL] [Abstract][Full Text] [Related]
26. Towards efficient immunotherapy for bacterial infection.
McCulloch TR; Wells TJ; Souza-Fonseca-Guimaraes F
Trends Microbiol; 2022 Feb; 30(2):158-169. PubMed ID: 34253452
[TBL] [Abstract][Full Text] [Related]
27. Urinary tract infections in women. Current unsatisfactory situation and prospects of a new therapeutic concept.
Rüttgers H; Grischke EM
Urol Int; 1987; 42(5):342-7. PubMed ID: 3433580
[TBL] [Abstract][Full Text] [Related]
28. Recent advances in bacterial cellulose-based antibacterial composites for infected wound therapy.
Meng S; Wu H; Xiao D; Lan S; Dong A
Carbohydr Polym; 2023 Sep; 316():121082. PubMed ID: 37321715
[TBL] [Abstract][Full Text] [Related]
29. Recent developments in detection and therapeutic approaches for antibiotic-resistant bacterial infections.
Moorthy K; Chang KC; Yang HH; Su WM; Chiang CK; Yuan Z
J Food Drug Anal; 2023 Mar; 31(1):1-19. PubMed ID: 37224551
[TBL] [Abstract][Full Text] [Related]
30. Micro-/Nanorobots in Antimicrobial Applications: Recent Progress, Challenges, and Opportunities.
Zhang Z; Wang L; Chan TKF; Chen Z; Ip M; Chan PKS; Sung JJY; Zhang L
Adv Healthc Mater; 2022 Mar; 11(6):e2101991. PubMed ID: 34907671
[TBL] [Abstract][Full Text] [Related]
31. Light-activated nanomaterials for tumor immunotherapy.
Wang F; Duan H; Xu W; Sheng G; Sun Z; Chu H
Front Chem; 2022; 10():1031811. PubMed ID: 36277335
[TBL] [Abstract][Full Text] [Related]
32. Recent Advances in Engineering Nanomedicines for Second Near-Infrared Photothermal-Combinational Immunotherapy.
Wang F; Zhu J; Wang Y; Li J
Nanomaterials (Basel); 2022 May; 12(10):. PubMed ID: 35630880
[TBL] [Abstract][Full Text] [Related]
33. Magnetic-controlled dandelion-like nanocatalytic swarm for targeted biofilm elimination.
Huang Y; Liu D; Guo R; Wang B; Liu Z; Guo Y; Dong J; Lu Y
Nanoscale; 2022 May; 14(17):6497-6506. PubMed ID: 35420115
[TBL] [Abstract][Full Text] [Related]
34. Application of Antimicrobial Peptides of the Innate Immune System in Combination With Conventional Antibiotics-A Novel Way to Combat Antibiotic Resistance?
Zharkova MS; Orlov DS; Golubeva OY; Chakchir OB; Eliseev IE; Grinchuk TM; Shamova OV
Front Cell Infect Microbiol; 2019; 9():128. PubMed ID: 31114762
[TBL] [Abstract][Full Text] [Related]
35. Tumor-Targeted Nanomedicine for Immunotherapy.
Cabral H; Kinoh H; Kataoka K
Acc Chem Res; 2020 Dec; 53(12):2765-2776. PubMed ID: 33161717
[TBL] [Abstract][Full Text] [Related]
36. Antimicrobial peptides for combating drug-resistant bacterial infections.
Xuan J; Feng W; Wang J; Wang R; Zhang B; Bo L; Chen ZS; Yang H; Sun L
Drug Resist Updat; 2023 May; 68():100954. PubMed ID: 36905712
[TBL] [Abstract][Full Text] [Related]
37. Progress and prospects in the management of bacterial infections and developments in Phytotherapeutic modalities.
Akram M; Riaz M; Munir N; Rasul A; Daniyal M; Ali Shah SM; Shariati MA; Shaheen G; Akhtar N; Parveen F; Akhter N; Owais Ghauri A; Chishti AW; Usman Sarwar M; Said Khan F
Clin Exp Pharmacol Physiol; 2020 Jul; 47(7):1107-1119. PubMed ID: 32064656
[TBL] [Abstract][Full Text] [Related]
38. [The history of the development and changes of quinolone antibacterial agents].
Takahashi H; Hayakawa I; Akimoto T
Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
[TBL] [Abstract][Full Text] [Related]
39. Nanomaterials-based photothermal therapy and its potentials in antibacterial treatment.
Chen Y; Gao Y; Chen Y; Liu L; Mo A; Peng Q
J Control Release; 2020 Dec; 328():251-262. PubMed ID: 32889053
[TBL] [Abstract][Full Text] [Related]
40. Molecular mechanism and potential application of bacterial infection in the silkworm, Bombyx mori.
Wang Q; Sun Z; Ma S; Liu X; Xia H; Chen K
Dev Comp Immunol; 2022 Jun; 131():104381. PubMed ID: 35245606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
